According to GlobalData’s Clinical Trials Database, among clinical trials for 2022, Phase II led with 40.1% of trials. This was followed by Phase I (28.8%), Phase III (25.4%), and Phase IV (15.4%). Q1 2022 had the greatest number of trials with 26.8%, followed closely by Q2 2022 with 26%.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,